PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF. Li J, Liang X, Jiang J, Yang L, et al. Gut 2022;71:163-175.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li J, Liang X, Jiang J, Yang L, et al. PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF. Gut 2022;71:163-175.
PMID: 33431576